Inhibition of p21-activated kinase rescues disrupted phenotype in a mouse model of CDKL5 deficiency disorder

被引：0
|
作者：
Talamo, M. C. [1 ]
Pellas, M. [1 ]
Urbinati, C. [1 ]
Cosentino, L. [1 ]
De Filippis, B. [1 ]
机构：
[1] Ist Super Sanita, Ctr Behav Sci & Mental Hlth, Rome, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.euroneuro.2019.12.062
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.236
引用
收藏
页码：S45 / S46
页数：3
相关论文
共 50 条
  • [21] Human neuronal CDKL5 knockout cells: a novel tool for the characterization of cellular and molecular mechanisms underlying CDKL5 deficiency disorder phenotype
    Loi, M.
    Trazzi, S.
    Fuchs, C.
    Medici, G.
    Gennaccaro, L.
    Ren, Elisa E.
    Tassinari, M.
    Galvani, G.
    Ciani, E.
    ACTA PHYSIOLOGICA, 2019, 227 : 150 - 150
  • [22] Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
    Katayama, Syouichi
    Sueyoshi, Noriyuki
    Inazu, Tetsuya
    Kameshita, Isamu
    NEURAL PLASTICITY, 2020, 2020
  • [23] P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer
    Zhang, Ding-Guo
    Gong, Chan-Chan
    Wu, Xiao-Jin
    Ren, Xin
    Sedaka, Randee S.
    Chen, Wei-Cong
    Huo, Fu-Chun
    Chen, Cheng
    Du, Wen-Qi
    Pei, Dong-Sheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [24] P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer
    Ding-Guo Zhang
    Chan-Chan Gong
    Xiao-Jin Wu
    Xin Ren
    Randee S. Sedaka
    Wei-Cong Chen
    Fu-Chun Huo
    Cheng Chen
    Wen-Qi Du
    Dong-Sheng Pei
    Signal Transduction and Targeted Therapy, 6
  • [25] mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder
    Gurgone, Antonia
    Pizzo, Riccardo
    Raspanti, Alessandra
    Chiantia, Giuseppe
    Devi, Sunaina
    Comai, Debora
    Morello, Noemi
    Pilotto, Federica
    Gnavi, Sara
    Lupori, Leonardo
    Mazziotti, Raffaele
    Sagona, Giulia
    Putignano, Elena
    Nocentini, Alessio
    Supuran, Claudiu T.
    Marcantoni, Andrea
    Pizzorusso, Tommaso
    Giustetto, Maurizio
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (06) : 877 - 886
  • [26] mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder
    Antonia Gurgone
    Riccardo Pizzo
    Alessandra Raspanti
    Giuseppe Chiantia
    Sunaina Devi
    Debora Comai
    Noemi Morello
    Federica Pilotto
    Sara Gnavi
    Leonardo Lupori
    Raffaele Mazziotti
    Giulia Sagona
    Elena Putignano
    Alessio Nocentini
    Claudiu T. Supuran
    Andrea Marcantoni
    Tommaso Pizzorusso
    Maurizio Giustetto
    Neuropsychopharmacology, 2023, 48 : 877 - 886
  • [27] Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder
    Tassinari, Marianna
    Mottolese, Nicola
    Galvani, Giuseppe
    Ferrara, Domenico
    Gennaccaro, Laura
    Loi, Manuela
    Medici, Giorgio
    Candini, Giulia
    Rimondini, Roberto
    Ciani, Elisabetta
    Trazzi, Stefania
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [28] A Novel Mouse Model Unveils Protein Deficiency in Truncated CDKL5 Mutations
    Feng, Xue
    Zhu, Zi-Ai
    Wang, Hong-Tao
    Zhou, Hui-Wen
    Liu, Ji-Wei
    Shen, Ya
    Zhang, Yu-Xian
    Xiong, Zhi-Qi
    NEUROSCIENCE BULLETIN, 2025, : 805 - 820
  • [29] Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset
    MacKay, Conor I.
    Wong, Kingsley
    Demarest, Scott T.
    Benke, Tim A.
    Downs, Jenny
    Leonard, Helen
    CLINICAL GENETICS, 2021, 99 (01) : 157 - 165
  • [30] Inhibition of myosin light chain kinase by p21-activated kinase
    Sanders, LC
    Matsumura, F
    Bokoch, GM
    de Lanerolle, P
    SCIENCE, 1999, 283 (5410) : 2083 - 2085
12345